Tuberculosis (TB) and human immunodeficiency virus (HIV) are closely correlated and continue to cause deleterious effects in co-infected patients. This study aimed to determine the prevalence and associated factors of TB/HIV co-infection among directly observed treatment short-course (DOTs) clinic clients in Ogun State, Nigeria.
Methods:
The TB register and treatment cards of patients that visited the DOTs centre in Federal Medical Centre Abeokuta between January 2015 and December 2019 were reviewed.
Results:
A total of 726 TB patients’ records were reviewed, among which 186 (22.5%) were co-infected with HIV. TB/HIV co-infection was significantly associated with the ⩽19 years age group 54 (37.2%), females 85 (26.7%), divorced and separated 8 (34.8%), rural residents 18 (34.0%), those who had no formal education 53 (39.8%) and the unemployed 63 (31.7%). Gender and educational status remained significant predictors of TB/HIV co-infection after adjustment for confounding factors.
Discussion:
Gender-sensitive programming and interventions geared towards improving knowledge of TB and HIV using a wide array of approaches should be considered.
FMoH. National tuberculosis catastrophic cost survey: report of the national survey to determine the proportion of TB patients and their households experiencing catastrophic cost due to TB. Federal Ministry of Health, 2017.
4.
NaidooKGengiahSSinghS, et al. Quality of TB care among people living with HIV: gaps and solutions. J Clin Tuberc Other Mycobact Dis2019; 17: 100122.
5.
UgwuKOAgboMCEzeonuIM.Prevalence of tuberculosis, drug-resistant tuberculosis, and hiv/tb co-infection in Enugu, Nigeria. Afr J Infect Dis2021; 15: 24–30.
6.
ReidMJAArinaminpathyNBloomA, et al. Building a tuberculosis-free world: the Lancet Commission on tuberculosis. Lancet (London, England)2019; 393: 1331–84.
7.
BruchfeldJCorreia-NevesMKälleniusG.Tuberculosis and HIV coinfection. Cold Spring Harb Perspect Med2015; 5: a017871.
8.
HiregoudarVRaghavendraBKarinagannavarA, et al. Proportion and determinants of tuberculosis among human immunodeficiency virus-positive patients attending the antiretroviral therapy center attached to a Medical College in South India. J Family Community Med2016; 23: 88–93.
9.
LawnSDMyerLBekkerLG, et al. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS (London, England)2006; 20: 1605–12.
10.
TesfayeBAlebelAGebrieA, et al. The twin epidemics: prevalence of TB/HIV co-infection and its associated factors in Ethiopia; a systematic review and meta-analysis. PLoS One2018; 13: e0203986.
11.
AdejumoOADanielOJOtesanyaAF, et al. Factors associated with tb/hiv co-infection among drug sensitive tuberculosis patients managed in a secondary health facility in Lagos, Nigeria. Afr J Infect Dis. 2017; 11: 75–82.
12.
National Population Commission (NPC). Federal Republic of Nigeria - IHSN survey catalog, population by sex, state, LGA, and senatorial district, 2006.
13.
IliyasuZBabashaniM.Prevalence and predictors of tuberculosis co-infection among HIV-seropositive patients attending the Aminu Kano Teaching Hospital, northern Nigeria. J Epidemiol2009; 19: 81–7.
14.
OladimejiOObasanyaJDanielOJ, et al. Factors associated with treatment success among pulmonary tuberculosis and HIV co-infected patients in Oyo state, Southwest-Nigeria. Niger Health J2013; 13: 75–84.
15.
BelayMBjuneGAbebeF.Prevalence of tuberculosis, HIV, and TB-HIV co-infection among pulmonary tuberculosis suspects in a predominantly pastoralist area, northeast Ethiopia. Glob Health Action2015; 8: 27949.
16.
RangeNMagnussenPMugomelaA, et al. HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Ann Trop Med Parasitol2007; 101: 343–51.
17.
AliyuNMagajiBA.Prevalence and factors associated with Tb-HIV co-infection among tuberculosis patients treated at Specialist Hospital, Sokoto State, Nigeria 2014-2017. Texila Int J Clin Res2019; 6: 1–7.
HIV/AIDS in Nigeria - pushing for the last mile [Internet].2019. https://ng.usembassy.gov › uploads › sites › (accessed 10 November 2021).
20.
GesesewHTsehainehBMassaD, et al. The role of social determinants on tuberculosis/HIV co-infection mortality in southwest Ethiopia: a retrospective cohort study. BMC Res Notes2016; 9: 89.
21.
Van WykBEDavidsLC. Challenges to HIV treatment adherence amongst adolescents in a low socio-economic setting in Cape Town. South Afr J HIV Med2019; 20: 1002.
22.
GirumTWasieALentiroK, et al. Gender disparity in epidemiological trend of HIV/AIDS infection and treatment in Ethiopia. Arch Public Health2018; 76: 51.
23.
AffusimCCKesiemeEAbahVO.The pattern of presentation and prevalence of tuberculosis in HIV-seropositive patients seen at Benin City, Nigeria. ISRN Pulmonol2012; 2012: 326572.
24.
ErhaborOJeremiahZAAdidasTC, et al. The prevalence of human immunodeficiency virus infection among TB patients in Port Harcourt Nigeria. HIV AIDS (Auckl)2010; 2: 1–5.
25.
IdowuAAOluwasegunAAMichaelO, et al. Prevalence and the risk factors associated with HIV-TB co-infection among clinic attendees in dots and art centres in Ibadan, Nigeria. CAJMNS2021; 2: 73–7.
26.
BelewHWubieMTizazuG, et al. Predictors of tuberculosis infection among adults visiting antiretroviral treatment center at east and west Gojjam, Northwest, Ethiopia, 2017. BMC Infect Dis2020; 20: 593.
27.
MitkuAADessieZGMulunehEK, et al. Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia. Afr Health Sci2016; 16: 588–95.
